Morphology and phenotype expression of types I, II, III, and X collagen and MMP-13 of chondrocytes cultured from articular cartilage of Kashin-Beck disease

Journal of Rheumatology

Volumn 35, Issue 4, 2008, Pages 696-702

  Wang, Weizhuo ^a   Guo, Xiong ^a   Chen, Junchang ^a   Xu, Peng ^a   Lammi, Mikko J ^b  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Cartilage; Chondrocytes; Collagen; Kashin Beck disease; Matrix metalloproteinases

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 10; COLLAGEN TYPE 2; COLLAGEN TYPE 3; COLLAGENASE 3;

ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CELL CULTURE; CELL STRUCTURE; CELL SUSPENSION; CELL ULTRASTRUCTURE; ELECTRON MICROSCOPE; FLOW CYTOMETRY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MICROSCOPY; OSTEOARTHROPATHY; PHENOTYPE; PRIORITY JOURNAL;

ADULT; CARTILAGE DISEASES; CARTILAGE, ARTICULAR; CELL NUCLEUS; CELLS, CULTURED; CHONDROCYTES; COLLAGEN TYPE X; FEMALE; FIBRILLAR COLLAGENS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; HYPERTROPHY; IMMUNOENZYME TECHNIQUES; MALE; MATRIX METALLOPROTEINASE 13;

EID: 41849105403     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Statistical Center of Ministry of Health, P.R. China. Statistical Bulletin of the Development Circumstance of Chinese Health Service in 2006 [updated 2007 May 9]. Available from: http://www.moh.gov.cn/newshtml/18903.htm. Accessed January 7, 2008.
2. National Kashin-Beck Disease Surveillance Group. Report of a national survey of Kashin-Beck disease prevalence in 2005. Chin J Endemiol 2006;25:670-2.
3. Yamamuro T. Kashin-Beck disease: a historical overview. Int Orthop 2001;25:134-7.
4. Guo X, Zhang SY, Mo DX. A role of low selenium in the occurrence of Kashin-Beck disease. J Xi'an Jiaotong Univ Med Sci 1992;4:99-108.
5. Yang JB. Etiology of Kashin-Beck disease. Chin J Endemiol 1995;14:201-4.
6. Peng A, Wang WH, Wang CX, et al. The role of humic substances in drinking water in Kashin-Beck disease in China. Environ Health Perspect 1999;107:293-6.
7. Tan J, Zhu W, Wang W, et al. Selenium in soil and endemic diseases in China. Sci Total Environ 2002;284:227-35.
8. Yang C, Niu C, Bodo M. Fulvic acid supplementation and selenium deficiency disturb the structural integrity of mouse skeletal tissue. Biochem J 1993;289:829-35.
9. Guo X. Diagnostic, clinical and radiological characteristics of Kashin-Beck disease in Shaanxi Province, PR China. Int Orthop 2001;25:147-50.
10. Pasteels JL, Liu FD, Hinsenkamp M, Rooze M, Mathieu F, Perlmutter N. Histology of Kashin-Beck lesions. Int Orthop 2001;25:151-3.
11. Guo X, Zuo H, Cao CX, et al. Abnormal expression of Col X, PTHrP, TGF-β, bFGF, and VEGF in cartilage with Kashin-Beck disease. J Bone Miner Metab 2006;24:319-28.
12. von der Mark K, Kirch T, Aigner T, et al. The fate of chondrocytes in osteoarthritic cartilage, regeneration, dedifferentiation, or hypertrophy. In: Kuettner KE, Schleyerbach R, Peyron JG, Hascall VC, editors. Articular cartilage and osteoarthritis. New York: Raven Press; 1992:221-34.
13. Schmid TM, Linsenmayer TF. Type X collagen. In: Mayne R, Burgeson RE, editors. Structure and function of collagen types. New York: Academic Press; 1987:223-59.
14. Birkedal-Hansen H, Moore WG, Bodden MK, et al. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 1993;4:197-250.
15. Saarialho-Kere UK. Patterns of matrix metalloproteinase and TIMP expression in chronic ulcers. Arch Dermatol Res 1998;290:47-54.
16. Mo DX. Histopathology of chondronecrosis in Kashin-Beck disease and its clinical significance. Chin J Control Endem Dis 1983;1:1-4.
17. Guo X, Aigner T, Lammi P, et al. A study on abnormal chondrocyte differentiation and abnormal expression of collagen types in AC from patients with Kashin-Beck disease. Chin J Pathol 1998;27:19-21.
18. Strehl R, Tallheden T, Sjögren-Jansson E, Minuth WW, Lindahl A. Long-term maintenance of human articular cartilage in culture for biomaterial testing. Biomaterials 2005;26:4540-9.
19. Bonaventure J, Kadhom N, Cohen-Solal L, et al. Reexpression of cartilage-specific genes by dedifferentiated human articular chondrocytes cultured in alginate beads. Exp Cell Res 1994;212:97-104.
20. Kolettas E, Buluwela L, Bayliss MT, Muir HI. Expression of cartilage-specific molecules is retained on long-term culture of human articular chondrocytes. J Cell Sci 1995;108:1991-9.
21. Stewart MC, Saunders KM, Burton-Wurster N, Macleod JN. Phenotypic stability of articular chondrocytes in vitro: The effects of culture models bone morphogenetic protein 2, and serum supplementation. J Bone Miner Res 2000;15:166-74.
22. Ministry of Public Health, China. Diagnostic criteria of Kashin-Beck disease. Chin J Endemiol 1994;13:24-32.
23. Jakob M, Demarteau O, Schafer D, Stumm M, Heberer M, Martin I. Enzymatic digestion of adult human articular cartilage yields a small fraction of the total available cells. Connect Tissue Res 2003;44:173-80.
24. Aigner T, Dietz U, Stoss H, von der Mark K. Differential expression of collagen types I, II, III, and X in human osteophytes. Lab Invest 1995;73:236-43.
25. Guo X. Molecular biological mechanism on chondronecrosis in cartilage with Kashin-Beck disease. J Xi'an Jiaotong Univ Med Sci 2005;26:201-4.
26. Roskelley CD, Bissell MJ. Dynamic reciprocity revisited: a continuous, bidirectional flow of information between cells and the extracellular matrix regulates mammary epithelial cell function. Biochem Cell Biol 1995;73:391-7.
27. Roskelley CD, Desprez PY, Bissell MJ. Extracellular matrix-dependent tissue-specific gene expression in mammary epithelial cells requires both physical and biochemical signal transduction. Proc Natl Acad Sci USA 1994;91:12378-82.
28. Roskelley CD, Srebrow A, Bissell MJ. A hierarchy of ECM-mediated signalling regulates tissue-specific gene expression. Curr Opin Cell Biol 1995;7:736-47.
29. Chen Q, Johnson DM, Haudenschild DR, Goetinck PF. Progression and recapitulation of the chondrocyte differentiation program: cartilage matrix protein is a marker for cartilage maturation. Dev Biol 1995;172:1-14.
30. Benya PD, Padilla SR, Nimni ME. Independent regulation of collagen types by chondrocytes during the loss of differentiated function in culture. Cell 1978;15:1313-21.
31. Benya PD, Shaffer JD. Dedifferentiated chondrocytes reexpress the differentiated collagen phenotype when cultured in agarose gels. Cell 1982;30:215-24.
32. Poole AR. Cartilage in health and disease. In: Koopman WJ, Moreland LW, editors. Arthritis and allied conditions. Baltimore: Williams and Wilkins; 2005:223-69.
33. Kempson GE, Muir H, Pollard C, Tuke M. The tensile properties of the cartilage of human femoral condyles related to the content of collagen and glycosaminoglycans. Biochim Biophys Acta 1973;297:456-72.
34. Billinghurst RC, Dahlberg L, Ionescu M, et al. Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. J Clin Invest 1997;99:1534-45.
35. Dahlberg L, Billinghurst C, Manner P, et al. Collagenase-mediated cleavage of type II collagen is selectively enhanced in osteoarthritis cartilage and can be arrested with a synthetic inhibitor which spares collagenase-1 (MMP-1). Arthritis Rheum 2000;43:673-82.
36. Wu W, Billinghurst RC, Pidoux I, et al. Sites of collagenase cleavage and denaturation of type II collagen in articular cartilage in ageing and osteoarthritis and their relationship to the distribution of the collagenases MMP-1 and MMP-13. Arthritis Rheum 2002;46:2087-94.
37. Hollander AP, Heathfield TF, Webber C, et al. Increased damage to type II collagen in osteoarthritic articular cartilage detected by a new immunoassay. J Clin Invest 1994;93:1722-32.
38. Hollander AP, Pidoux I, Reiner A, Rorabeck C, Bourne R, Poole AR. Damage to type II collagen in ageing and osteoarthritis: starts at the articular surface, originates around chondrocytes and extends into the cartilage with progressive degeneration. J Clin Invest 1995;96:2859-69.
39. Yang CL, Bodo M, Notbohm H, Peng A, Muller PK. Fulvic acid disturbs processing of procollagen II in articular cartilage of embryonic chicken and may also cause Kashin-Beck disease. Eur J Biochem 1991;202:1141-6.
40. Aigner T, Bertling W, Stross H, Weseloh G, von der Mark K. Independent expression of fibril-forming collagens I, II and III in chondrocytes of human osteoarthritic cartilage. J Clin Invest 1993;91:829-37.
41. Kultti A, Rilla K, Tiihonen R, Spicer AP, Tammi RH, Tammi MI. Hyaluronan synthesis induces microvillus-like cell surface protrusions. J Biol Chem 2006;281:15821-8.
42. Girkontaite I, Frischholz S, Lammi P, et al. Immunolocalization of type X collagen in normal fetal and adult osteoarthritic cartilage with monoclonal antibodies. Matrix Biol 1996;15:231-8.
43. Lammi P, Lammi MJ, Hyttinen MM, Panula H, Kiviranta I, Helminen HJ. Site-specific immunostaining for type X collagen in noncalcified articular cartilage of canine stifle knee joint. Bone 2002;31:690-6.
44. Schmid TM, Cole AA, Chen Q, Bonen DK, Luchene L, Linsenmayer TF. Assembly of type X collagen by hypertrophic chondrocytes. In: Yurchenko PE, Birk DE, Mecham RP, editors. Extracellular matrix assembly and structure. San Diego: Academic Press; 1994:171-206.
45. Kwan KM, Pang MK, Zhou S, et al. Abnormal compartmentalization of cartilage matrix components in mice lacking collagen X: Implications for function. J Cell Biol 1997;136:459-71.
46. Bode W, Maskos K. Structural basis of the matrix metalloproteinases and their physiological inhibitors, the tissue inhibitors of metalloproteinases. Biol Chem 2003;384:863-72.
47. Wu W, Tchetina E, Mwale F, et al. Proteolysis involving MMP-13 (collagenase-3) and the expression of the chondrocyte hypertrophic phenotype. J Bone Miner Res 2002;17:639-51.
48. Yasuda T, Tchetina E, Ohsawa K, et al. Peptides of type II collagen can induce the cleavage of type II collagen and aggrecan in articular cartilage. Matrix Biol 2006;25:419-29.
49. Hecht JT, Hayes E, Haynes R, Cole WG. COMP mutations, chondrocyte function and cartilage matrix. Matrix Biol 2005;23:525-33.